REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 145 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,135 | +64.0% | 441,584 | +1514.9% | 0.01% | +33.3% |
| Q2 2023 | $692 | -99.9% | 27,345 | -62.0% | 0.01% | -50.0% |
| Q2 2022 | $995,000 | +38.4% | 71,966 | +63.4% | 0.01% | +71.4% |
| Q4 2021 | $719,000 | -18.0% | 44,037 | +39.9% | 0.01% | -41.7% |
| Q3 2021 | $877,000 | -8.3% | 31,472 | -2.4% | 0.01% | +9.1% |
| Q2 2021 | $956,000 | +5.9% | 32,250 | -0.2% | 0.01% | -15.4% |
| Q1 2021 | $903,000 | +92.9% | 32,319 | +95.8% | 0.01% | +160.0% |
| Q4 2020 | $468,000 | -78.3% | 16,507 | -80.7% | 0.01% | -88.4% |
| Q3 2020 | $2,153,000 | +78.5% | 85,659 | +73.4% | 0.04% | +38.7% |
| Q2 2020 | $1,206,000 | +531.4% | 49,396 | +319.9% | 0.03% | +675.0% |
| Q4 2019 | $191,000 | – | 11,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |